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Background: Patients with non-ischemic cardiomyopathy (NICMP) are often difficult to risk stratify since several comorbidities may be present 
that alter the clinical picture. We used cardiac magnetic resonance (CMR) imaging to find an objective, reproducible and measureable method for 
risk stratifying patients based on myocardial replacement fibrosis (RF) and diffuse interstitial fibrosis.
Methods: We enrolled 93 consecutive patients with NICMP who underwent delay enhancement cardiac magnetic resonance (DE-CMR) and 
T1 mapping using a modified look-locker inversion recovery (MOLLI) technique. The extent of RF was determined by visual inspection using the 
American Heart Association 17-segment model without knowledge of any other clinical factors. The extracellular volume (ECV) was estimated from 
the concentration of extracellular contrast agent in the myocardium relative to the blood in the dynamic steady state. Care was taken to avoid 
measuring ECV in regions with RF detected on DE-CMR.
results: The cohort consisted of 61.3% of patients with some extent of RF. In the group of patients with RF, the mean scar burden and ECV in 
the left ventricle myocardium were 7.5±9.8% and 35.7±10.9%, respectively. Twelve patients (12.8%) died or received a heart transplant during 
the follow up average period of 1.75 years. A significant relationship between the number of clinical events and the percent scar (p<0.016) and 
ECV (p<0.014) was found. Adverse event rates increase significantly when the ECV value is greater than 38% (p<0.002) or the percent scar is scar 
greater than 5% of the myocardium (p<0.004). All-cause mortality rates increase as the percentage of scar increases (p<0.049).
conclusion: This study suggests that patients with replacement fibrosis greater than 5% and extracellular volume greater than 38% had 
significantly higher rates of death and need for heart transplant. Also, this shows that cardiac magnetic resonance could be a viable noninvasive tool 
in risk stratifying non-ischemic cardiomyopathy patients.
